Literature DB >> 11032169

The IAP family: endogenous caspase inhibitors with multiple biological activities.

Y L Yang1, X M Li.   

Abstract

IAPs (inhibitors of apoptosis) are a family of proteins containing one or more characteristic BIR domains. These proteins have multiple biological activities that include binding and inhibiting caspases, regulating cell cycle progression, and modulating receptor-mediated signal transduction. Our recent studies found the IAP family members XIAP and c-IAP1 are ubiquitinated and degraded in proteasomes in response to apoptotic stimuli in T cells, and their degradation appears to be important for T cells to commit to death. In addition to three BIR domains, each of these IAPs also contains a RING finger domain. We found this region confers ubiquitin protease ligase (E3) activity to IAPs, and is responsible for the auto-ubiquitination and degradation of IAPs after an apoptotic stimulus. Given the fact that IAPs can bind a variety of proteins, such as caspases and TRAFs, it will be of interest to characterize potential substrates of the E3 activity of IAPs and the effects of ubiquitination by IAPs on signal transduction, cell cycle, and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11032169     DOI: 10.1038/sj.cr.7290046

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  76 in total

1.  Illumina sequencing revealed roles of microRNAs in different aluminum tolerance of two citrus species.

Authors:  Yang-Fei Zhou; Yan-Yu Wang; Wei-Wei Chen; Li-Song Chen; Lin-Tong Yang
Journal:  Physiol Mol Biol Plants       Date:  2020-10-27

2.  The time course of Akt and ERK activation on XIAP expression in HEK 293 cell line.

Authors:  Mousa Abkhezr; Ali Reza Keramati; Seyed Nasser Ostad; Jamshid Davoodi; Mohammad H Ghahremani
Journal:  Mol Biol Rep       Date:  2009-08-02       Impact factor: 2.316

3.  Survivin: a potential prognostic marker and chemoradiotherapeutic target for colorectal cancer.

Authors:  C Xiaoyuan; C Longbang; W Jinghua; G Xiaoxiang; G Huaicheng; Z Qun; S Haizhu
Journal:  Ir J Med Sci       Date:  2009-11-17       Impact factor: 1.568

4.  The apoptosis inhibitor survivin prevents insect midgut from cell death during postembryonic development.

Authors:  Hong-Juan He; Li Hou; Jin-Xing Wang; Xiao-Fan Zhao
Journal:  Mol Biol Rep       Date:  2011-06-03       Impact factor: 2.316

Review 5.  Protein S-nitrosylation: role for nitric oxide signaling in neuronal death.

Authors:  Neelam Shahani; Akira Sawa
Journal:  Biochim Biophys Acta       Date:  2011-07-23

6.  Expression Analysis of Survivin and XIAP in Gallbladder Cancer: a Case-control Study in Indo-Gangetic Plain.

Authors:  Ruhi Dixit; Mohd Raza; Mohan Kumar; S Basu; V K Shukla
Journal:  J Gastrointest Cancer       Date:  2018-12

7.  Overexpression of apoptosis-related protein, survivin, in fibroblasts from patients with systemic sclerosis.

Authors:  Mohammad Bagher Mahmoudi; Ehsan Farashahi Yazd; Farhad Gharibdoost; Mohammad Hasan Sheikhha; Elham Karimizadeh; Ahmadreza Jamshidi; Mahdi Mahmoudi
Journal:  Ir J Med Sci       Date:  2019-02-13       Impact factor: 1.568

8.  CPT21, a novel compound with anti-proliferative effect against gastric cancer cell SGC7901.

Authors:  Bo Zhang; Yu Luo; Qinjie Weng; Qiaojun He; Wei Lu; Bo Yang
Journal:  Invest New Drugs       Date:  2008-02-19       Impact factor: 3.850

9.  IAP inhibitors enhance co-stimulation to promote tumor immunity.

Authors:  Michael Dougan; Stephanie Dougan; Joanna Slisz; Brant Firestone; Matthew Vanneman; Dobrin Draganov; Girija Goyal; Weibo Li; Donna Neuberg; Richard Blumberg; Nir Hacohen; Dale Porter; Leigh Zawel; Glenn Dranoff
Journal:  J Exp Med       Date:  2010-09-13       Impact factor: 14.307

10.  Overexpression of X-linked inhibitor of apoptosis protein (XIAP) is an independent unfavorable prognostic factor in childhood de novo acute myeloid leukemia.

Authors:  Ki Woong Sung; Jaewon Choi; Yu Kyeong Hwang; Sang Jin Lee; Hee-Jin Kim; Ju Youn Kim; Eun Joo Cho; Keon Hee Yoo; Hong Hoe Koo
Journal:  J Korean Med Sci       Date:  2009-07-29       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.